Policy | July 11, 2025
EU launches strategies to strengthen crisis readiness and health security
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
This global affiliation marks a critical step in the company’s mission to create long-term value through ethical practices, scientific innovation, and inclusive healthcare delivery
The company's first-ever corporate-level submission to EcoVadis builds on years of operational and environmental excellence
Aarti Pharmalabs becomes 6th Indian Pharma/CDMO to earn SBTi approval for all 3 Scopes since 2022 demerger
Over the last two years, Lupin has showcased exceptional improvement in its EcoVadis scoring
Biotech potential of Himalayan territories including Jammu & Kashmir, particularly their agri-biotech potential remains still under-explored
The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25
The session focused on “Biomanufacturing of Enzymes,” a critical domain under the BioE3 Policy.
In the near term, the company targets a 42% reduction in absolute Scope 1 and 2 emissions and Scope 3 emissions by FY2030
The report highlights Piramal Pharma’s approach across four key strategic pillars: Responsible Operations, Business Resilience, Customer Centricity, and Quality & Excellence
Subscribe To Our Newsletter & Stay Updated
